Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
QuantumPharm, Inc. ( (HK:2228) ) has provided an announcement.
XtalPi Holdings Limited has announced a strategic move to place 264 million new shares under a general mandate, priced at HK$4.28 per share. This placement represents approximately 7.73% of its current issued share capital, aiming to raise gross proceeds of HK$1,130 million. This initiative, which does not require additional shareholder approval, is expected to provide significant capital to support the company’s operations and growth in the competitive pharmaceutical market.
More about QuantumPharm, Inc.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., operates in the pharmaceutical industry, focusing on innovative drug discovery and development. The company is incorporated in the Cayman Islands and is publicly traded with a stock code of 2228.
YTD Price Performance: -22.24%
Average Trading Volume: 83,824,502
Technical Sentiment Consensus Rating: Strong Buy
Learn more about 2228 stock on TipRanks’ Stock Analysis page.